Table 1.
Effects of Serotonin and Dopamine Receptor Agonists on Resting Hemodynamic Parameters
| Drugs | Resting parameters | |||||
|---|---|---|---|---|---|---|
| Name | Type | Delivery | Con. (μg/kg) | Animals (n) | MAP | HR |
| 8-OH-DPAT | 5-HT1A agonist | s.c. | Basal | 4 | 109.2 ± 2.8 | 476 ± 17 |
| Low (5.0) | 106.7 ± 4.0 | 487 ± 15 | ||||
| Mid (20) | 107.0 ± 3.8 | 484 ± 16 | ||||
| High (100) | 104.1 ± 7.6 | 396 ± 23 | ||||
| DOI | 5-HT2A agonist | Basal | 9 | 106.3 ± 3.2 | 448 ± 19 | |
| Low (5.0) | 116.4 ± 3.6** | 467 ± 21 | ||||
| Mid (20) | 132.5 ± 3.9** | 440 ± 16 | ||||
| High (100) | 146.5 ± 8.8** | 425 ± 18 | ||||
| DOI | 5-HT2A agonist | i.t. | Basal | 4 | 92.2 ± 2.7 | 339 ± 18 |
| Low (1.0) | 97.1 ± 1.7 | 341 ± 17 | ||||
| Mid (4.0) | 104.1 ± 1.1* | 342 ± 11 | ||||
| High (20) | 111.1 ± 3.6* | 313 ± 12 | ||||
| Apomorphine | Non-selective DA receptor agonist | s.c. | Basal | 7 | 102.8 ± 3.8 | 445 ± 24 |
| Low (10) | 104.9 ± 3.2 | 453 ± 21 | ||||
| Mid (100) | 106.0 ± 3.3 | 432 ± 17 | ||||
| High (300) | 101.7 ± 3.2 | 431 ± 11* | ||||
*p < 0.05, **p < 0.01, repeated measures ANOVA followed by Fisher's PLSD.
ANOVA, analysis of variance; DOI, Dimethoxy-4-iodoamphetamine; i.t., intrathecal; HR, heart rate; MAP, mean arterial pressure; s.c., subcutaneous.